Happy New Year (2026)
New year, same mission — just a little less stress? 🥂
In Pharmaceutical Manufacturing Construction and Technology
At procurement, qualification and validation
Open up our chat service to get quick answers and speak with company representatives.
By Colin Young on January 6, 2026
New year, same mission — just a little less stress? 🥂
By Colin Young on December 9, 2025
You know that feeling when you’ve just completed a massive project, validation is complete, and you’re ready to ship product? That sweet relief is immediately followed by the cold dread of realizing the FDA Pre-Approval Inspection (PAI) is looming…
In aseptic manufacturing, the PAI isn’t just an inspection -it’s the regulatory World Series, the Aseptic Olympics- success demands a flawless routine without dropping any SOPs. The medal is market access; the judge is the FDA.
By Colin Young on December 4, 2025
The transition to the revised EU GMP Annex 1 (2022) demands a shift from simply building a clean space to engineering a comprehensive Contamination Control Strategy (CCS). Validation issues are often rooted in the design phase, where planning assumptions misalign with operational reality.
If your facility design does not thoroughly address risks associated with operator interventions or material and equipment transfer to sterile areas, you are potentially compromising your sterility assurance.
By GPharma Webmaster on December 1, 2025
Welcome to the GPharma Solutions blog!
Here we will be posting current goings-on with the company in addition to informative posts regarding subjects relevant to the services we provide. You may easily find posts based on the category of post and/or tags indicating its subject!
This blog also supports RSS. If you wish to take advantage of this, use the following link: https://gpharmasolutions.com/blog/index.xml
More to come soon. Stay tuned!
Copyright (c) 2025, GPharma Solutions Ltd; all rights reserved.
Template by Bootstrapious. Ported to Hugo by DevCows.